Patrick Heron
InvestorManaging Partner at Frazier Life Sciences · Managing Partner at Frazier Healthcare Partners · Board director at Passage Bio · Board director at Scout Bio Inc · Board director at Recida Therapeutics
Palo Alto
About
Patrick Heron co-leads Frazier's Life Sciences team and is a Managing Partner and co-founder of that team, having joined the firm in 1999 and opened its Palo Alto office in 2003. He invests across therapeutics, from early-stage drug development to commercial-stage pharmaceutical companies. Before Frazier, he helped build McKinsey & Company's West Coast biotechnology consulting practice, and he holds an M.B.A. from Harvard Business School and a B.A. from the University of North Carolina at Chapel Hill.
Contact· self-published, not guessed
Invests in
Biotech
Board director at Passage Bio
Intro paths
In turn, Patrick can intro founders to Passage Bio's investors below.
Passage Bio's investors · 7
Board director at Scout Bio Inc
Intro paths
In turn, Patrick can intro founders to Scout Bio Inc's investors below.
Board director at Recida Therapeutics
Intro paths
In turn, Patrick can intro founders to Recida Therapeutics's investors below.
Recida Therapeutics's investors · 1
Experience
- Frazier Life SciencesManaging Partnercurrent1999 — presentPalo Alto, California, United States
- Alpha-9 OncologyBoard Chaircurrent2022 — presentBoston, Massachusetts, United States
- Mirum PharmaceuticalsBoard Membercurrent2018 — presentSan Francisco Bay Area
- Alceptor TherapeuticsBoard Membercurrent2020 — present
- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT)Board Membercurrent2016 — present
- MBX Biosciences, Inc.Board Membercurrent2020 — presentIndianapolis, Indiana, United States
- BlueWater Biosciences, IncBoard Membercurrent2024 — present
- Aspen Neuroscience, Inc.Board Observercurrent2020 — presentSan Diego, California, United States
- Gates FoundationInvestment Committee Member - Strategic Investment Fundcurrent2020 — presentSeattle, Washington, United States
- Tubulis GmbHBoard Member2025 — 2026Munich, Bavaria, Germany
- HilleVaxBoard Member2021 — 2025Boston, Massachusetts, United States
- SanReno TherapeuticsBoard Member2022 — 2023Shanghai, China
- Scout BioChairman of the Board2018 — 2023Greater Philadelphia
- IMAGO BIOSCIENCES LTDBoard Member2014 — 2022San Francisco Bay Area
- VaxcyteBoard Member2017 — 2021Redwood City
- Passage BioBoard Member2018 — 2021Greater Philadelphia
- Iterum Therapeutics LimitedBoard Member2015 — 2021Dublin, Ireland
- AmunixBoard Member2019 — 2021San Francisco Bay Area
- Zavante Therapeutics, Inc.Board Member2016 — 2018San Diego, California
- Silvergate PharmaceuticalsBoard Member2011 — 2018Denver, CO
- QuatRxBoard Member2000 — 2017Ann Arbor, Michigan
- VentiRx PharmaceuticalsBoard Member2007 — 2016Seattle
- Tobira TherapeuticsBoard Member2007 — 2016San Francisco Bay Area
- Collegium PharmaceuticalBoard Member2008 — 2016
- CalibriumBoard Member2013 — 2015Greater Indianapolis
- Cidara TherapeuticsBoard Member2014 — 2015San diego
- Precision DermatologyBoard Member2010 — 2014Cumberland, Rhode Island
- Marcadia BiotechBoard Member2006 — 2010Greater Indianapolis
- Trubion PharmaceuticalsBoard Member2002 — 2010Greater Seattle Area
- CalixaBoard Member2007 — 2009San Francisco Bay Area
- PanomicsBoard Member2000 — 2008San Francisco Bay Area
- CerexaBoard Member2005 — 2007San Francisco Bay Area
- MedPointe PharmaceuticalsBoard Observer2001 — 2007
- McKinsey & CompanyEngagement Manager, Associate, Analyst1992 — 1999
Skills & more
+8 more
HealthcareInvestor RelationsEntrepreneurshipFinancial ModelingGrowth CapitalAngel InvestingLife SciencesStrategyFrom Patrick's professional profile.
Deals · 18
Mirum PharmaceuticalsBoard seat
via Frazier Life Sciences · filed Jan 2026 · $68.5M raise
Imago BioSciences, Inc.Board seat
via Frazier Life Sciences · filed Nov 2020 · $80M raise
SutroVaxBoard seat
via Frazier Life Sciences · filed Apr 2020 · $110M raise
Iterum Therapeutics BermudaBoard seat
via Frazier Life Sciences · filed Jan 2020 · $51.6M raise
Arcutis BiotherapeuticsBoard seat
via Frazier Life Sciences · filed Oct 2019 · $94.5M raise
Passage BioBoard seat
via Frazier Life Sciences · filed Sep 2019 · $110M raise
Recida TherapeuticsBoard seat
via Frazier Life Sciences · filed Jul 2018 · $10.7M raise
SG PharmaceuticalsBoard seat
via Frazier Life Sciences · filed Apr 2016 · $45.7M raise
Silvergate PharmaceuticalsBoard seat
via Frazier Life Sciences · filed Oct 2015 · $4.6M raise
Nexcida TherapeuticsBoard seat
via Frazier Life Sciences · filed Jun 2015 · $21.3M raise
Collegium PharmaceuticalBoard seat
via Frazier Life Sciences · filed Mar 2015 · $50M raise
Cidara TherapeuticsBoard seat
via Frazier Life Sciences · filed Feb 2015 · $42M raise
IgnytaLed round
via Frazier Life Sciences · filed Nov 2015
CalixaLed round
CerexaLed round
CollegiumLed round
MarcadiaLed round
PreCision DermatologyLed round
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
Imago BioSciencesKrystalMedPointeTobira TherapeuticsVaxcyte
Board seats
AlceptorAlpha‑9Birdseye TherapeuticsBlueWater TherapeuticsBreakwater TherapeuticsMBX BiosciencesMBX Biosciences
Sources: the firm's website · SEC Form D filings.
Colleagues at Frazier Life Sciences
Network1
Investors connected to Patrick in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Patrick Heron?
- Patrick Heron co-leads Frazier's Life Sciences team and is a Managing Partner and co-founder of that team, having joined the firm in 1999 and opened its Palo Alto office in 2003. He invests across therapeutics, from early-stage drug development to commercial-stage pharmaceutical companies. Before Frazier, he helped build McKinsey & Company's West Coast biotechnology consulting practice, and he holds an M.B.A. from Harvard Business School and a B.A. from the University of North Carolina at Chapel Hill.
- Where does Patrick Heron work?
- Patrick Heron is Managing Partner at Frazier Life Sciences and Board director at Passage Bio and Board director at Scout Bio Inc and Board director at Recida Therapeutics.
- What does Patrick Heron invest in?
- Patrick Heron invests in Biotech.
- What boards does Patrick Heron sit on?
- Patrick Heron holds tracked board seats at Alceptor, Alpha‑9, Arcutis Biotherapeutics, Arcutis Biotherapeutics, Birdseye Therapeutics, BlueWater Therapeutics, Breakwater Therapeutics, Cidara Therapeutics, Collegium Pharmaceutical, Imago BioSciences, Inc..
- What companies has Patrick Heron invested in?
- Investments tracked here include Calixa, Cerexa, Collegium, Ignyta, Imago BioSciences, Krystal, Marcadia, MedPointe, PreCision Dermatology, Silvergate Pharmaceuticals, Tobira Therapeutics, Vaxcyte.
- Where did Patrick Heron go to school?
- Patrick Heron studied at Harvard Business School (MBA); The University of North Carolina at Chapel Hill (BA, Political Science).
- Does Patrick Heron lead rounds?
- Yes — Patrick Heron has led 12 tracked investments.
Same school
Also attended Harvard Business School2,000
+ 1,994 more
Also attended The University of North Carolina at Chapel Hill321
+ 315 more
)
